New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

XLVvsETF 2ETF Comparison

ETF 1
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
+0.9%
VS
ETF 2
Suggested XLV comparisons

Choose a second ETF to run a side-by-side ETF comparison with XLV, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLV performance and flow charts

Performance

-2.00.02.04.06.0%Sep 22Sep 29Oct 6Oct 13Oct 20

Cumulative Flows

0 B0.5 B1 B1.5 B2 BSep 22Sep 29Oct 6Oct 13Oct 20

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/22/2026
1M3MYTD1Y3Y5Y
Perf.
XLV
ETF 2
+6.72%–
+14.19%–
+18.57%–
+26.26%–
+49.70%–
+49.31%–
Flows
XLV
ETF 2
+$1.66B–
+$454M–
+$1.21B–
+$2.09B–
-$3.45B–
+$4.70B–
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLV
ETF 2
+17.55%–
+16.30%–
+14.96%–
+15.25%–
Max drawdown
XLV
ETF 2
-5.81%–
-10.51%–
-17.05%–
-17.05%–
Max drawdown duration
XLV
ETF 2
56d–
116d–
444d–
444d–
Trading data

Create an account to view trading data

Join for free
XLV
ETF 2
Last sale
10/23/2026 at 6:37 PM
$178.99
–
Previous close
10/22/2026
$181.30
–
Consolidated volume
10/22/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XLV
ETF 2
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/23/2026 at 6:37 PM
Live
Closed
XLV
ETF 2
Last price
$178.99
–
1D performance
-1.28%
–
AuM$47.68 B–
E/R0.08%–
Characteristics
XLV
ETF 2
Management strategyPassive–
ProviderState Street Investment Management–
BenchmarkS&P Health Care Select Sector Index–
N° of holdings59–
Asset classEquities–
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 1998–
ESGNo–
Advertisement
Exposure

Countries

XLV
USA
97.52%
Other
2.48%
ETF 2

Sectors

XLV
Healthcare
97.84%
Other
2.16%
ETF 2
Advertisement

Diversification

XLV

Total weight of top 15 holdings out of 15

71.32%
ETF 2
–

Top 15 holdings

Data as of August 31, 2026
XLV
Eli Lilly & Co.
14.88%
Johnson & Johnson
10.41%
AbbVie, Inc.
7.37%
Merck & Co., Inc.
5.93%
UnitedHealth Group, Inc.
5.75%
Amgen, Inc.
3.77%
Thermo Fisher Scientific, Inc.
3.73%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.95%
Pfizer Inc.
2.64%
Vertex Pharmaceuticals, Inc.
2.25%
Bristol Myers Squibb Co.
2.22%
Danaher Corp.
2.19%
Intuitive Surgical, Inc.
2.17%
CVS Health Corp.
1.95%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026